Return To Sender, Industry Groups Say Of AER Address Guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA's recommendation for complete addresses on OTC and dietary supplement product labels in order to comply with the adverse event reporting law exceeds not only Congress's intent, but also the requirements for all other products regulated by the agency, industry groups say
You may also be interested in...
Final AER Guidance Requires Full Address, Recommends Prefatory Language
In its final adverse event reports labeling guidance documents released Sept. 1, FDA does not budge on defining "domestic address" as a full mailing address, or on recommending labels include statements directing consumers how to submit AERs
FDA Lacks Legal Sway To Enforce AER Label Revisions – Attorney
There is little chance FDA will aggressively enforce changes to dietary supplement and OTC drug labels recommended in the adverse event report labeling guidance, a food and drug attorney says
FDA Estimates Dollar Costs For Adverse Event Labeling But Doubts Persist
FDA's estimate of nearly $44 million for the dietary supplement industry to revise labels to comply with the adverse event reporting law may understate the actual burden by leaving out some key costs